Enzo Biochem (ENZ) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to Enzo Biochem (ENZ) Misses Q2 EPS by 1c

Enzo Biochem Reports Increased Fiscal Second Quarter Results

March 9, 2016 4:05 PM EST

Molecular Diagnostics Spurs Double-Digit Clinical Lab Revenue Gains, Contributes to Consolidated Net Income of $6.8 Million

NEW YORK--(BUSINESS WIRE)-- Enzo Biochem, Inc. (NYSE: ENZ) today reported results for the second fiscal quarter and fiscal first half ended January 31, 2016, led by strong gains at Enzo Clinical Labs reflecting increased molecular diagnostic testing demand.

Among the quarters highlights:

Revenues of $24.6 million grew 6% year over year, including a 19% increase at Enzo Clinical Labs Net income of $6.8 million, or $0.15 per... More